<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.47395.055</object-id><label>Table 1.</label><caption><title><italic>E. coli</italic> strains, plasmids and primers used in this study.</title></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Relevant properties or genotype</th><th>Source or reference</th></tr></thead><tbody><tr><td><italic>E. coli</italic> strains</td><td/><td/></tr><tr><td>DH5&#945;</td><td><italic>supE44,</italic> &#916;<italic>lacU169</italic> (&#966;<italic>80 lacZ</italic>&#916;<italic>M15</italic>) <italic>hsdR17 recA1 endA1 hsdR gyrA relA thi</italic></td><td>Invitrogen</td></tr><tr><td>BL21(DE3)</td><td><italic>F&#8211; ompT gal dcm lon hsdSB(rB- mB-) &#955;(DE3 [lacI lacUV5- T7 gene one ind1 sam7 nin5])</italic></td><td>Stratagene, Santa Clara, CA</td></tr><tr><td>Plasmids</td><td/><td/></tr><tr><td>pEXA_fbpB</td><td>Amp<sup>R</sup> pEX-A128 vector carrying synthesized <italic>fbpB</italic> gene from <italic>M. bovis</italic></td><td>Eurofins Genomics</td></tr><tr><td>pET22b (+)</td><td>Amp<sup>R</sup>, vector for overexpression of genes in <italic>E. coli</italic></td><td>Novagen</td></tr><tr><td>pET22b-fbpB</td><td>Amp<sup>R</sup>, vector for overexpression of <italic>fbpB</italic> gene in <italic>E. coli</italic> BL21(DE3)</td><td>This study</td></tr><tr><td>Primers</td><td colspan="2">Sequence (5&#8217; -&#160;&gt;&#160;3&#8217;)</td></tr><tr><td>fbpB-fw</td><td colspan="2">CCCCATATGTTCTCTCGTCCGG</td></tr><tr><td>fbpB-rv</td><td colspan="2">CCCCTCGAGACCAGCACCCAG</td></tr></tbody></table><table-wrap-foot><fn><p><sup>*</sup> Amp<sup>R</sup>, ampicillin resistance.</p></fn></table-wrap-foot></table-wrap>